FDA dramatically narrows use of Johnson & Johnson Covid-19 vaccine

The Food and Drug Administration has restricted the use of the Johnson & Johnson Covid-19 vaccine to adults who are unable or unwilling to get the Pfizer-BioNTech or Moderna mRNA shots.

The decision comes after the agency completed an updated risk analysis of developing thrombosis with thrombocytopenia syndrome, or TTS, a rare and possibly fatal combination of blood clots and low platelet counts one to two weeks after receiving the vaccine, the agency said Thursday.

Given the severity

→ Continue reading at Politico

[ufc-fb-comments url="http://www.newyorkmetropolitan.com/news/fda-dramatically-narrows-use-of-johnson-johnson-covid-19-vaccine"]

Latest Articles

Related Articles